The receptive language measure information-carrying word (ICW) level, is used extensively by speech and language therapists in the UK and Ireland. Despite this it has never been validated via its relationship to any other relevant measures. This study aims to validate the ICW measure by investigating the relationship between the receptive ICW score of children with specific language impairment (SLI) and their performance on standardized memory and language assessments. Twenty-seven children with SLI, aged between 5;07 and 8;11, completed a sentence comprehension task in which the instructions gradually increased in number of ICWs. The children also completed subtests from The Working Memory Test Battery for children and The Clinical Evaluation of Language Fundamentals- 4. Results showed that there was a significant positive relationship between both language and memory measures and children's ICW score. While both receptive and expressive language were significant in their contribution to children's ICW score, the contribution of memory was solely determined by children's working memory ability. ICW score is in fact a valid measure of the language ability of children with SLI. However therapists should also be cognisant of its strong association with working memory when using this construct in assessment or intervention methods.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495434 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180496 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension.
EClinicalMedicine
August 2024
Keck School of Medicine of USC, Los Angeles, CA, USA.
Background: Cold agglutinin disease (CAD) is a rare subtype of autoimmune haemolytic anaemia characterised by classical complement pathway-mediated haemolysis, fatigue, and poor quality of life (QoL). Sutimlimab, a C1s inhibitor, rapidly halted haemolysis, and improved patient-reported outcomes (PROs) in patients with CAD in two phase 3 trials (CARDINAL and CADENZA). Here we report PROs from the CADENZA open-label extension (Part B).
View Article and Find Full Text PDFLong-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B.
EClinicalMedicine
August 2024
Division of Hematology, MedStar Georgetown University Hospital, Washington, DC, USA.
Article Synopsis
- Cold agglutinin disease (CAD) is a rare autoimmune condition causing anemia, and sutimlimab, which inhibits a key part of the immune system, showed effectiveness in reducing symptoms like hemolysis and fatigue in the CADENZA Part A study.
- In Part B of the CADENZA study, 32 out of 39 patients continued treatment for about 99 weeks, showing sustained improvements in hemoglobin, bilirubin levels, and quality of life measures, with no severe adverse effects reported.
- Despite the promising results, stopping sutimlimab led to a return of disease symptoms, indicating that while the treatment is effective, continuous management is necessary to maintain its benefits.
A cross-sectional survey study on the correlation analysis of nutritional status and intestinal flora in patients with esophageal cancer.
Front Nutr
July 2024
Department of Nutrition, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Objective: This study aims to examine the nutritional status of individuals diagnosed with esophageal cancer and compare the nutritional indicators and intestinal flora between malnourished and non-malnourished patients. The findings aim to contribute to the early prevention of malnutrition and the development of interventions targeting the intestinal flora to treat esophageal cancer.
Methods: An 80-patient sample of hospitalized individuals with esophageal cancer was selected from the radiotherapy department of our hospital between July 2021 and July 2022 to evaluate NRS2002 scores and PG-SGA scores.
Post-treatment stability, survival time and periodontal health associated with vacuum-formed, bonded and rapid prototype retainers: A prospective clinical study.
J Orthod
June 2024
Department of Orthodontics and Dentofacial Orthopaedics, Sri Ramachandra Dental College and Hospital, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Background: New technologies have paved the way for newer fabrication techniques, such as rapid prototyping, which has gained popularity in the fabrication of several orthodontic appliances including retainers.
Aim: To evaluate the stability, survival time and periodontal health associated with vacuum-formed retainers (VFRs), bonded retainers (BRs) and rapid prototype retainers (RPRs) over a period of 12 months in retention.
Study Design: Prospective clinical study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!